Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF MIDDLE EAST AND AFRICA SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 PRODUCT LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 VENDOR SHARE ANALYSIS
2.11 MARKET END USER COVERAGE GRID
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTEL ANALYSIS
4.2 PORTER'S ANALYSIS
5 REGULATORY FRAMEWORK
5.1 REGULATORY GUIDANCE AS PER U.S. FDA.
5.2 REGULATORY SCENARIO FOR EUROPEAN UNION
5.3 REGULATORY SCENARIO IN JAPAN
5.4 REGULATORY FRAMEWORK IN CHINA
6 PIPELINE ANALYSIS
7 MARKET OVERVIEW
7.1 DRIVERS
7.1.1 INCREASING PREVALENCE OF CHRONIC DISEASES
7.1.2 PRODUCT APPROVAL OF SMALL MOLECULE
7.1.3 HIGH R&D INVESTMENT FOR SMALL MOLECULE DEVELOPEMNT
7.1.4 STRONG PIPELINE FOR SMALL MOLECULE INJECTABLE
7.1.5 GROWTH IN GENERIC INJECTABLES
7.2 RESTRAINTS
7.2.1 HIGH LEVEL OF QUALITY AND CARE REQUIRED IN THE PRODUCTION
7.2.2 HIGH MANUFACTURING AND PURCHASING COST OF INJECTABLES
7.2.3 STRINGENT REGULATIONS FOR FACILITES AND EQUIPMENTS REQUIRED FOR SMALL MOLECULES INJECTABLE
7.2.4 PRODUCT RECALL
7.3 OPPORTUNITIES
7.3.1 STRATEGIC INITIATIVES BY KEY MARKET PLAYERS
7.3.2 GROWING PRODUCT LAUNCHES
7.3.3 RISING PER CAPTIA INCOME AND HEALTHCARE EXPENDITURE
7.4 CHALLENGES
7.4.1 LACK OF ACCESSIBILITY
7.4.2 HIGH COST OF DIAGNOSIS & TREATMENT
8 IMPACT OF COVID-19 ON THE MIDDLE EAST AND AFRICA SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET
8.1 OVERVIEW AFTERMATH OF COVID-19 AND GOVERNMENT ROLE
8.2 IMPACT ON PRICE
8.3 IMPACT ON DEMAND
8.4 IMPACT ON SUPPLY CHAIN
8.5 STRATEGIC DECISIONS OF GOVERNMENT AND MANUFACTURERS
8.6 CONCLUSION
9 MIDDLE EAST AND AFRICA SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY PRODUCT
9.1 OVERVIEW
9.2 VIAL FILLING
9.3 SYRINGE FILLING
9.4 CARTRIDGE FILLING
9.5 OTHERS
10 MIDDLE EAST AND AFRICA SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY APPLICATION
10.1 OVERVIEW
10.2 ONCOLOGY
10.3 INFECTIOUS DISEASES
10.4 CARDIOVASCULAR DISEASES
10.5 METABOLIC DISEASES
10.6 NEUROLOGY
10.7 UROLOGY
10.8 DERMATOLOGY
10.9 AUTOIMMUNE DISEASES
10.1 RESPIRATORY DISORDERS
10.11 OTHERS
11 MIDDLE EAST AND AFRICA SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY END USER
11.1 OVERVIEW
11.2 HOSPITALS
11.3 SPECIALTY CLINICS
11.4 HOMECARE SETTING
11.5 OTHERS
12 MIDDLE EAST AND AFRICA SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY DISTRIBUTION CHANNEL
12.1 OVERVIEW
12.2 DIRECT TENDER
12.3 RETAIL PHARMACY
12.4 ONLINE PHARMACY
12.5 OTHERS
13 MIDDLE EAST AND AFRICA SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY REGION
13.1 MIDDLE EAST AND AFRICA
13.1.1 SOUTH AFRICA
13.1.2 SAUDI ARABIA
13.1.3 U.A.E.
13.1.4 EGYPT
13.1.5 ISRAEL
13.1.6 ETHIOPIA
13.1.7 REST OF MIDDLE EAST & AFRICA
14 MIDDLE EAST AND AFRICA SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, COMPANY LANDSCAPE
14.1 COMPANY SHARE ANALYSIS: MIDDLE EAST AND AFRICA
15 SWOT ANALYSIS
16 COMPANY PROFILE
16.1 PFIZER INC.
16.1.1 COMPANY SNAPSHOT
16.1.2 REVENUE ANALYSIS
16.1.3 COMPANY SHARE ANALYSIS
16.1.4 SERVICE PORTFOLIO
16.2 GILEAD SCIENCES, INC.
16.2.1 COMPANY SNAPSHOT
16.2.2 REVENUE ANALYSIS
16.2.3 COMPANY SHARE ANALYSIS
16.2.4 PRODUCT PORTFOLIO
16.2.5 RECENT DEVELOPMENTS
16.3 TEVA PHARMACEUTICAL INDUSTRIES LTD.
16.3.1 COMPANY SNAPSHOT
16.3.2 REVENUE ANALYSIS
16.3.3 COMPANY SHARE ANALYSIS
16.3.4 PRODUCT PORTFOLIO
16.3.5 RECENT DEVELOPMENTS
16.4 FRESENIUS KABI USA (ASUBSIDIARY OF FRESENIUS SE & CO. KGAA).
16.4.1 COMPANY SNAPSHOT
16.4.2 REVENUE ANALYSIS
16.4.3 COMPANY SHARE ANALYSIS
16.4.4 PRODUCT PORTFOLIO
16.4.5 RECENT DEVELOPMENT
16.5 ABBVIE INC.
16.5.1 COMPANY SNAPSHOT
16.5.2 REVENUE ANALYSIS
16.5.3 PRODUCT PORTFOLIO
16.5.4 RECENT DEVELOPMENTS
16.6 AMERICAN REGENT, INC. (A DAIICHI SANKYO GROUP COMPANY)
16.6.1 COMPANY SNAPSHOT
16.6.2 REVENUE ANALYSIS
16.6.3 PRODUCT PORTFOLIO
16.6.4 RECENT DEVELOPMENTS
16.7 AMGEN INC.
16.7.1 COMPANY SNAPSHOT
16.7.2 REVENUE ANALYSIS
16.7.3 PRODUCT PORTFOLIO
16.7.4 RECENT DEVELOPMENTS
16.8 AMOMED PHARMA GMBH
16.8.1 COMPANY SNAPSHOT
16.8.2 PRODUCT PORTFOLIO
16.8.3 RECENT DEVELOPMENTS
16.9 ASTRAZENECA
16.9.1 COMPANY SNAPSHOT
16.9.2 REVENUE ANALYSIS
16.9.3 PRODUCT PORTFOLIO
16.9.4 RECENT DEVELOPMENTS
16.1 BIOCRYST PHARMACEUTICALS, INC.
16.10.1 COMPANY SNAPSHOT
16.10.2 REVENUE ANALYSIS
16.10.3 PRODUCT PORTFOLIO
16.10.4 RECENT DEVELOPMENTS
16.11 BRISTOL-MYERS SQUIBB COMPANY
16.11.1 COMPANY SNAPSHOT
16.11.2 REVENUE ANALYSIS
16.11.3 PRODUCT PORTFOLIO
16.11.4 RECENT DEVELOPMENTS
16.12 EISAI CO., LTD.
16.12.1 COMPANY SNAPSHOT
16.12.2 PRODUCT PORTFOLIO
16.12.3 RECENT DEVELOPMENTS
16.13 EXELIXIS, INC.
16.13.1 COMPANY SNAPSHOT
16.13.2 REVENUE ANALYSIS
16.13.3 PRODUCT PORTFOLIO
16.13.4 RECENT DEVELOPMENT
16.14 GENENTECH, INC. (A SUBSIDIARY OF F. HOFFMANN-LA ROCHE LTD)
16.14.1 COMPANY SNAPSHOT
16.14.2 REVENUE ANALYSIS
16.14.3 PRODUCT PORTFOLIO
16.14.4 RECENT DEVELOPMENTS
16.15 HIKMA PHARMACEUTICALS PLC
16.15.1 COMPANY SNAPSHOT
16.15.2 REVENUE ANALYSIS
16.15.3 PRODUCT PORTFOLIO
16.15.4 RECENT DEVELOPMENTS
16.16 MERCK SHARP & DOHME CORP., A SUBSIDIARY OF MERCK & CO., INC.
16.16.1 COMPANY SNAPSHOT
16.16.2 REVENUE ANALYSIS
16.16.3 PRODUCT PORTFOLIO
16.16.4 RECENT DEVELOPMENTS
16.17 NEUREN PHARMACEUTICALS
16.17.1 COMPANY SNAPSHOT
16.17.2 PRODUCT PORTFOLIO
16.17.3 RECENT DEVELOPMENTS
16.18 NOXOPHARM
16.18.1 COMPANY SNAPSHOT
16.18.2 PRODUCT PORTFOLIO
16.18.3 RECENT DEVELOPMENTS
16.19 SANOFI
16.19.1 COMPANY SNAPSHOT
16.19.2 REVENUE ANALYSIS
16.19.3 PRODUCT PORTFOLIO
16.19.4 RECENT DEVELOPMENT
16.2 TELIGENT
16.20.1 COMPANY SNAPSHOT
16.20.2 REVENUE ANALYSIS
16.20.3 PRODUCT PORTFOLIO
16.20.4 RECENT DEVELOPMENT
17 QUESTIONNAIRE
18 RELATED REPORTS
List of Table
TABLE 1 MIDDLE EAST AND AFRICA SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, PIPELINE ANALYSIS
TABLE 2 NUMBER OF PEOPLE WITH DIABETES (MILLION) AMONG AGES 20–79 YEARS
TABLE 3 PER CAPITA AMOUNTS: UNITED STATES (1960–2017 YEARS)
TABLE 4 MIDDLE EAST AND AFRICA SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 5 MIDDLE EAST AND AFRICA VIAL FILLING IN SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 6 MIDDLE EAST AND AFRICA SYRINGE FILLING IN SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 7 MIDDLE EAST AND AFRICA CARTRIDGE FILLING IN SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 8 MIDDLE EAST AND AFRICA OTHERS IN SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 9 MIDDLE EAST AND AFRICA SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 10 MIDDLE EAST AND AFRICA ONCOLOGY IN SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 11 MIDDLE EAST AND AFRICA INFECTIOUS DISEASES IN SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 12 MIDDLE EAST AND AFRICA CARDIOVASCULAR DISEASE IN SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 13 MIDDLE EAST AND AFRICA METABOLIC DISEASES IN SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 14 MIDDLE EAST AND AFRICA NEUROLOGY IN SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 15 MIDDLE EAST AND AFRICA UROLOGY IN SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 16 MIDDLE EAST AND AFRICA DERMATOLOGY IN SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 17 MIDDLE EAST AND AFRICA AUTOIMMUNE DISEASES IN SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 18 MIDDLE EAST AND AFRICA RESPIRATORY DISORDERS IN SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 19 MIDDLE EAST AND AFRICA OTHERS IN SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 20 MIDDLE EAST AND AFRICA SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 21 MIDDLE EAST AND AFRICA HOSPITALS IN SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 22 MIDDLE EAST AND AFRICA SPECIALTY CLINICS IN SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 23 MIDDLE EAST AND AFRICA HOMECARE SETTING IN SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 24 MIDDLE EAST AND AFRICA OTHERS IN SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 25 MIDDLE EAST AND AFRICA SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 26 MIDDLE EAST AND AFRICA DIRECT TENDER IN SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 27 MIDDLE EAST AND AFRICA RETAIL PHARMACY IN SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 28 MIDDLE EAST AND AFRICA ONLINE PHARMACY IN SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 29 MIDDLE EAST AND AFRICA OTHERS IN SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 30 MIDDLE EAST AND AFRICA SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY COUNTRY, 2019-2028 (USD MILLION)
TABLE 31 MIDDLE EAST AND AFRICA SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 32 MIDDLE EAST AND AFRICA SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 33 MIDDLE EAST AND AFRICA SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 34 MIDDLE EAST AND AFRICA SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 35 SOUTH AFRICA SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 36 SOUTH AFRICA SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 37 SOUTH AFRICA SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 38 SOUTH AFRICA SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 39 SAUDI ARABIA SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 40 SAUDI ARABIA SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 41 SAUDI ARABIA SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 42 SAUDI ARABIA SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 43 U.A.E. SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 44 U.A.E. SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 45 U.A.E. SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 46 U.A.E. SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 47 EGYPT SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 48 EGYPT SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 49 EGYPT SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 50 EGYPT SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 51 ISRAEL SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 52 ISRAEL SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 53 ISRAEL SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 54 ISRAEL SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 55 ETHIOPIA SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 56 ETHIOPIA SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 57 ETHIOPIA SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 58 ETHIOPIA SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 59 REST OF MIDDLE EAST & AFRICA SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
List of Figure
FIGURE 1 MIDDLE EAST AND AFRICA SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET: SEGMENTATION
FIGURE 2 MIDDLE EAST AND AFRICA SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET: DATA TRIANGULATION
FIGURE 3 MIDDLE EAST AND AFRICA SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET: DROC ANALYSIS
FIGURE 4 MIDDLE EAST AND AFRICA SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET: MIDDLE EAST AND AFRICA VS. REGIONAL MARKET ANALYSIS
FIGURE 5 MIDDLE EAST AND AFRICA SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 MIDDLE EAST AND AFRICA SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET: MULTIVARIATE MODELLING
FIGURE 7 MIDDLE EAST AND AFRICA SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET: PRODUCT LIFELINE CURVE
FIGURE 8 MIDDLE EAST AND AFRICA SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 9 MIDDLE EAST AND AFRICA SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET: DBMR MARKET POSITION GRID
FIGURE 10 MIDDLE EAST AND AFRICA SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET: VENDOR SHARE ANALYSIS
FIGURE 11 MIDDLE EAST AND AFRICA SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET: MARKET END USER COVERAGE GRID
FIGURE 12 MIDDLE EAST AND AFRICA SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET: SEGMENTATION
FIGURE 13 THE GROWING GERIATRIC POPULATION IS EXPECTED TO DRIVE THE MIDDLE EAST AND AFRICA SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 14 PRODUCT SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE MIDDLE EAST AND AFRICA SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 15 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGE OF MIDDLE EAST AND AFRICA IMMUNOASSAYS-GAMMA COUNTER MARKET
FIGURE 16 THE GRAPH BELOW SHOWS THE INCREASING PREVALENCE OF CHRONIC DISEASES IN 1995 TO FORECAST 2030 IN THE U.S.
FIGURE 17 MIDDLE EAST AND AFRICA SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET: BY PRODUCT, 2020
FIGURE 18 MIDDLE EAST AND AFRICA SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET: BY PRODUCT, 2021-2028 (USD MILLION)
FIGURE 19 MIDDLE EAST AND AFRICA SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET: BY PRODUCT, CAGR (2021-2028)
FIGURE 20 MIDDLE EAST AND AFRICA SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET: BY PRODUCT, LIFELINE CURVE
FIGURE 21 MIDDLE EAST AND AFRICA SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET: BY APPLICATION, 2020
FIGURE 22 MIDDLE EAST AND AFRICA SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET: BY APPLICATION, 2021-2028 (USD MILLION)
FIGURE 23 MIDDLE EAST AND AFRICA SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET: BY APPLICATION, CAGR (2021-2028)
FIGURE 24 MIDDLE EAST AND AFRICA SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 25 MIDDLE EAST AND AFRICA SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET: BY END USER, 2020
FIGURE 26 MIDDLE EAST AND AFRICA SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET: BY END USER, 2021-2028 (USD MILLION)
FIGURE 27 MIDDLE EAST AND AFRICA SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET: BY END USER, CAGR (2021-2028)
FIGURE 28 MIDDLE EAST AND AFRICA SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET: BY END USER, LIFELINE CURVE
FIGURE 29 MIDDLE EAST AND AFRICA SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET: BY DISTRIBUTION CHANNEL, 2020
FIGURE 30 MIDDLE EAST AND AFRICA SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET: BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)
FIGURE 31 MIDDLE EAST AND AFRICA SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET: BY DISTRIBUTION CHANNEL, CAGR (2021-2028)
FIGURE 32 MIDDLE EAST AND AFRICA SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 33 MIDDLE EAST AND AFRICA SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET: SNAPSHOT (2020)
FIGURE 34 MIDDLE EAST AND AFRICA SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET: BY COUNTRY (2020)
FIGURE 35 MIDDLE EAST AND AFRICA SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET: BY COUNTRY (2021 & 2028)
FIGURE 36 MIDDLE EAST AND AFRICA SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET: BY COUNTRY (2020 & 2028)
FIGURE 37 MIDDLE EAST AND AFRICA SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET: BY PRODUCT (2021-2028)
FIGURE 38 MIDDLE EAST AND AFRICA SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET: COMPANY SHARE 2020 (%)
